Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID) in the Intravescical Therapy of Patients With Non-muscle Invasive Cancer of the Bladder. A Phase II Marker Lesion. STUDY

NCT04661826 is registered in ClinicalTrials.gov with Fidia Farmaceutici s.p.a. as lead sponsor.

NCT NCT04661826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04661826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID) in the Intravescical Therapy of Patients With Non-muscle Invasive Cancer of the Bladder. A Phase II Marker Lesion. STUDY
Lead sponsor
Fidia Farmaceutici s.p.a.
Phase
Phase 2
Overall status
Completed
Start date
May 17, 2010
Completion date
October 4, 2016
Enrollment
60 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

non-invasive papillary carcinoma of bladder